Dyslipidemia in an HIV-positive antiretroviral treatment-naive population in Dar es Salaam, Tanzania

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 2, 2011, Pages 141-145

  Armstrong, Catharina ^a   Liu, Enju ^a   Okuma, James ^a   Spiegelman, Donna ^a   Guerino, Chalamilla ^b   Njelekela, Marina ^b   Grinspoon, Steve ^c   Fawzi, Wafaie ^a   Hawkins, Claudia ^b,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MANAGEMENT AND DEVELOPMENT FOR HEALTH   (Tanzania)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

ART naive; cardiovascular disease; dyslipidemia; HIV positive; Tanzania

Indexed keywords

ANTIRETROVIRUS AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; FEMALE; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TANZANIA; URBAN AREA;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HIV INFECTIONS; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; PREVALENCE; TANZANIA; TRIGLYCERIDES;

EID: 79957934149     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318219a3d1     Document Type: Article

References (36)

1. UNAIDS, World Health Organization (WHO). AIDS Epidemic Update. UNAIDS. Geneva, Switzerland: WHO; 2009.
2. The Writing Committee of the DAD Study Group. Cardio and cerebrovascular events in HIV infected persons. AIDS. 2004;15: 1811-1817.
3. Riddler SA, Smit E, Cole SR, et al. Impact of HIV infection and HAART on serum lipids in men. JAMA. 2003;289:2978-2982. (Pubitemid 37430100)
4. Grunfeld C, Doerrler W, Pang M, et al. Abnormalities of apolipoprotein E in the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1997;82:3734-3740. (Pubitemid 27509363)
5. Hellerstein MK, Grunfeld C, Wu K, et al. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab. 1993;76:559-565. (Pubitemid 23086466)
6. Fourie CM, Van Rooyen JM, Kruger A, et al. Lipid abnormalities in a Never-treated HIV-1 subtype C-Infected african population. Lipids. 2010;45:73-80.
7. Pujari SN, Dravid A, Naik E, et al. Lipodystrophy and dyslipidemia among patients taking firstline,World Health Organization-recommended highly active antiretroviral therapy regimens in western India. J Acquir Immune Defic Syndr. 2005;39:199-202. (Pubitemid 40741119)
8. Manuthu EM, Joshi, MD, Lule GN, et al. Prevalence of dyslipidemia in HIV infected patients. East Afr Med J. 2008;85:10-17.
9. Buchacz K, Weidle PJ, Moore D, et al. Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home based aids care program in rural Uganda. J Acquir Immune Defic Syndr. 2008;47:304-311. (Pubitemid 351619415)
10. Anastos K, Ndamage F, Lu D, et al. Lipoprotein levels and cardiovascular risk in HIVinfected and uninfected Rwandan women. AIDS Res Ther. 2010; 7:1-6.
11. Hemelaar J, Gouws E, Ghys PD, et al.Global and regional distribution ofHIV-1 genetic subtypes and recombinants in 2004. AIDS. 2006;16:W13-W23. (Pubitemid 44611051)
12. Tanzania Commission for AIDS (TACAIDS). Tanzania HIV/AIDS and Malaria Indicator Survey 2007-2008: Preliminary Report. July 2008.
13. The United Republic of Tanzania, Ministry of Health and Social Welfare. National Guidelines for the Management of HIV and AIDS, National AIDS Control Programme (NACP). 3rd ed. 2008.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
15. NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
16. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
17. Swai AB, McLarty DG, Kitange HM, et al. Low prevalence of risk factors for coronary heart disease in rural Tanzania. Int J Epidemiol. 1993;22: 651-659. (Pubitemid 23247567)
18. Triant VA, Lee H, Hadigan C, et al. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with Human Immunodeficiency Virus disease. J Clin Endocrinol Metab. 2007;92: .2506. E-pub: April 24, 2007.
19. Friis-Moller N, Sabin CA, Weber R, et al. Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group 2003 Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 1993;349:1993-2003.
20. Mary-Krause M, Cotte L, Simon A, et al. Clinical Epidemiology Group from the French Hospital Database Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS. 2003;17:2479-2486. (Pubitemid 38393320)
21. World Health Organization (WHO). Mortality Report Cause of Death. Geneva, Switzerland: WHO; 2007:1-250.
22. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27: 1047-5330.
23. Stewart S,Wilkinson D, Becker A, et al. Mapping the Emergence of Heart Disease in a Black Urban Population in Africa: The heart of Soweto Study. Int J Cardiol. 2006;108:101-108. (Pubitemid 43324914)
24. Akinboboye O, Idris O, Akinkugbe O. Trends in coronary artery disease and associated risk factors in Sub Saharan Africans. J Hum Hypertens. 2003;17:381-387. (Pubitemid 36722202)
25. Grunfeld C, Kotler DP, Shigenaga JK, et al. Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome AIDS. Am J Med. 1991;90:154-162.
26. Feingold KR, Krauss RM, Pang M, et al. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of LDL subclass B. J Clin Endocrinol Metab. 1993;76: 1423-1427. (Pubitemid 23164355)
27. Shor-Posner G, Basit A, Lu Y, et al. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med. 1993;94:515-519. (Pubitemid 23142967)
28. Kaplan RC, Kingsley LA, Gange SJ, et al. Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS. 2008;22:1615-1624.
29. Lichtenstein KA, Armon C, Buchacz K, et al. Initiation of antiretroviral therapy at CD4 cell counts $350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency. J Acquir Immune Defic Syndr. 2008;47:27-37.
30. Triant VA, Regan S, Lee H, et al. Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system. J Acquir Immune Defic Syndr. 2010. E-pub ahead of print.
31. Grunfeld C, Pang M, Doerrler W, et al. Lipids, lipoprotein, triglyceride clearance and cytokines in HIV/AIDS. J Clin Endocrinol Metab. 1992;74: 1045-1052.
32. Rose H, Hoy J,Woolley I, et al. HIV infection and high density lipoprotein metabolism. Atherosclerosis. 2008;199:79-86. (Pubitemid 351842701)
33. McNamara JR, Cohn JS, Wilson PW, et al. Calculated values for low density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem. 1990;36:36-42.
34. Lu W, Resnick HE, Jabionski KA, et al. Non-HDL Cholesterol as a predictor of cardiovascular disease in Type 2 Diabetes: the Strong Heart Study. Diabetes Care. 2003;26:16-23. (Pubitemid 36928989)
35. van Leth F, Phanuphak P, Stroes E, et al. Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1. PLoS Med. 2004;1:e19.
36. Govindarajulu US, Malloy EJ, Ganguli B, et al. The Comparison of Alternative Smoothing Methods for Fitting Non-Linear Exposure-Response Relationships with Cox Models in a Simulation Study. Int J Biostat. 2009;7:5(1):Article2.